Funding for this research was provided by:
National Natural Science Foundation of China (82000180, 82170205, 82130003)
Zhejiang Key R&D Program (2021C03010)
Received: 13 January 2023
Accepted: 8 March 2023
First Online: 18 March 2023
: The scientific board of the ALWP of EBMT approved this study. All patients gave written informed consent for the use of their data.
: Not applicable for individual patient data. This is a pooled analysis.
: The authors declare that they have no competing interests.